CRYBG2 and hepatocellular carcinoma: After the 5-fold cross validation, parameters including TTK, ANLN, AIM1L and person neoplasm cancer status were recruited to be underlying candidates of OS in HCC patients when λ took the minimum value (Figure 2a).